Farid Hamedi‐Sangsari

Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.

Serge Malley, J M Grange, Farid Hamedi‐Sangsari et al. · Proceedings of the National Academy of Sciences · 1994 · 74 citations

Life Sciences, Immunology, Pharmacology +17

Anti-HIV Activity of the Combination of Didanosine and Hydroxyurea in HIV-1-Infected Individuals

F. Biron, Fr d ric Lucht, D. Peyramond et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1995 · 55 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +16

Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals

F. Biron, Frédéric Lucht, D. Peyramond et al. · Antiviral Research · 1996 · 25 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Anti‐tumoral activity of L and D isomers of aspartic acid β‐hydroxamate on L5178Y leukemia

Nicole Thomasset, Farid Hamedi‐Sangsari, Roselyne Tournaire et al. · International Journal of Cancer · 1991 · 18 citations

Medicine, Oncology, Pharmacology +8

Therapeutic effects of D‐aspartic acid β‐hydroxamate (DAH) on friend erythroleukemia

Roselyne Tournaire, Serge Malley, Farid Hamedi‐Sangsari et al. · International Journal of Cancer · 1994 · 16 citations

Medicine, Hematology, Pharmacology +6